Oragenics, Inc., and Ricci Pharma Sign Agreement Expected to Provide EvoraPlus(R) and EvoraKids(TM) to the United Nations, UNESCO, UNICEF, World Health Organization and The Food and Agriculture Organization

TAMPA, Fla.--(BUSINESS WIRE)--Florida-based biotechnology company Oragenics, Inc., (OTCBB:ORNI) (www.oragenics.com) and RICCI PHARMA (www.riccipharma.com), a recognized health products company with offices in Rome and Slovakia, have entered into a distribution agreement that the parties anticipate will provide Oragenics’ proprietary oral care probiotic products, EvoraPlus® and EvoraKidsTM, to RICCI PHARMA. RICCI PHARMA will have exclusive distribution rights through Duc in Altum, a foundation whose humanitarian projects are inspired by the social teachings of the late Pope John Paul II. Duc in Altum’s honorary chairman is the Polish Pope’s former private secretary for over 30 years, Cardinal Stanislaw Dziwisz, currently Archbishop of Krakow. The foundation, whose projects are known by the Holy See and encouraged by Vatican Secretary of State Cardinal Tarcisio Bertone, is expected to further promote Oragenics’ products with the Church’s capillary network of health services as well as with international organizations such as the United Nations (www.un.org), UNESCO (www.unesco.org), UNICEF (www.unicef.org), World Health Organization (www.who.int), and the Food and Agriculture Organization (www.fao.org) in Africa, Asia, South America and the Caribbean.